LKB1 inactivation is involved in tumorigenesis [123], it is the third most frequently mutated gene in adenocarcinoma [124], and somatic mutations of LKB1 have been reported in 20–30% of NSCLC and derivative cell lines [124,125,126,127,128]. Here, STK11 is linked to adenocarcinoma.